Cefmetazole structure
|
Common Name | Cefmetazole | ||
---|---|---|---|---|
CAS Number | 56796-20-4 | Molecular Weight | 471.534 | |
Density | 1.8±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C15H17N7O5S3 | Melting Point | 163-165ºC | |
MSDS | N/A | Flash Point | N/A |
Use of CefmetazoleCefmetazole (CS 1170) is a semisynthetic cephamycin antibiotic with broad-spectrum antibacterial activity, covering gram-positive, gram-negative and anaerobic bacteria. Cefmetazole binds to penicillin binding proteins (PBPs), resulting in interfering bacterial cell wall biosynthesis. Cefmetazole is used for the research of gynecologic, intraabdominal, urinary tract, respiratory tract and skin and soft tissue infections[1][2][3]. |
Name | cefmetazole |
---|---|
Synonym | More Synonyms |
Description | Cefmetazole (CS 1170) is a semisynthetic cephamycin antibiotic with broad-spectrum antibacterial activity, covering gram-positive, gram-negative and anaerobic bacteria. Cefmetazole binds to penicillin binding proteins (PBPs), resulting in interfering bacterial cell wall biosynthesis. Cefmetazole is used for the research of gynecologic, intraabdominal, urinary tract, respiratory tract and skin and soft tissue infections[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | Cefmetazole (CS 1170) has antibiotic affinity to S. aureus with a MIC value of 1.0 mg/L. Cefmetazole has affinity for PBP1, PBP2 and PBP3 with IC50 values of ≤0.3, 0.109 and 0.494 mg/L[1]. |
In Vivo | Cefmetazole (CS 1170) (100 mg/kg; i.h.; twice a day, for 7 days; male ICR mice) alters gut bacterial flora[3]. Animal Model: Male ICR mice[3] Dosage: 100 mg/kg Administration: Subcutaneous injection; twice a day, for 7 days Result: Reduced Peyer's patch (PP) lymphocyte cell numbers while decreased bacterial numbers in the small intestine. |
References |
Density | 1.8±0.1 g/cm3 |
---|---|
Melting Point | 163-165ºC |
Molecular Formula | C15H17N7O5S3 |
Molecular Weight | 471.534 |
Exact Mass | 471.045319 |
PSA | 239.23000 |
LogP | 0.97 |
Index of Refraction | 1.798 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~% Cefmetazole CAS#:56796-20-4 |
Literature: Journal of Antibiotics, , vol. 29, # 5 p. 554 - 558 |
~% Cefmetazole CAS#:56796-20-4 |
Literature: Journal of Antibiotics, , vol. 29, # 9 p. 969 - 972 |
~% Cefmetazole CAS#:56796-20-4 |
Literature: Journal of Antibiotics, , vol. 29, # 9 p. 969 - 972 |
~% Cefmetazole CAS#:56796-20-4 |
Literature: Journal of Antibiotics, , vol. 29, # 5 p. 554 - 558 |
~% Cefmetazole CAS#:56796-20-4 |
Literature: Journal of Antibiotics, , vol. 29, # 9 p. 969 - 972 |
~% Cefmetazole CAS#:56796-20-4 |
Literature: Journal of Antibiotics, , vol. 29, # 5 p. 554 - 558 |
Long-Term Colonization by bla(CTX-M)-Harboring Escherichia coli in Healthy Japanese People Engaged in Food Handling.
Appl. Environ. Microbiol. 82 , 1818-27, (2016) The actual state of intestinal long-term colonization by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in healthy Japanese people remains unclear. Therefore, a total of 4,314 fecal s... |
(6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
cefmetazolum [INN_la] |
(6R,7S)-7-({[(Cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
(6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
Cefmetazole |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[2-[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)- |
EINECS 260-384-2 |
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)- |
MFCD00214260 |